Cargando…

Recurrent Exacerbations and Evolution into Polymyositis in a Patient with Interstitial Pneumonia with Autoimmune Features: A Case Report and Literature Review

Interstitial pneumonia with autoimmune features (IPAF) is a new disease entity proposed in 2015. Numerous questions regarding IPAF require clarification, including diagnostic criteria, standard managements for stable disease and exacerbation, and prognosis. We report a case of a 67-year-old Asian wo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chien-Tzu, Ou, Tsan-Teng, Hsu, Jui-Sheng, Cheng, Chih-Hung, Sheu, Chau-Chyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962511/ https://www.ncbi.nlm.nih.gov/pubmed/36837534 http://dx.doi.org/10.3390/medicina59020330

Ejemplares similares

Unilateral Autoimmune Pulmonary Alveolar Proteinosis with Polymyositis-related Interstitial Lung Disease
por: Muto, Yutaka, et al.
Publicado: (2022)

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Reversible platypnea-orthodeoxia syndrome induced by rapidly progressive interstitial pneumonia in a patient with polymyositis
por: Yamakawa, Hideaki, et al.
Publicado: (2014)

Granulomatous interstitial polymyositis and intramuscular neuritis in a dog
por: Hultman, Josefin, et al.
Publicado: (2021)

Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report
por: Sato, S., et al.
Publicado: (2020)

Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases
por: Chiang, Hui-Ling, et al.
Publicado: (2021)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Characteristics and risk of interstitial lung disease in dermatomyositis and polymyositis: a retrospective cohort study in Japan
por: Hu, Qingqing, et al.
Publicado: (2023)

Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis
por: Lim, Jeong Uk, et al.
Publicado: (2019)

The Risk Factors of Exacerbation in Interstitial Pneumonia With Autoimmune Features: A Single-Center Observational Cohort Study
por: Murata, Okinori, et al.
Publicado: (2021)

COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia
por: Kitayama, Takaaki, et al.
Publicado: (2020)

Polymyositis and fatal interstitial pneumonia following pelvic irradiation that led to unexpectedly severe adverse effects: a case report
por: Oike, Takahiro, et al.
Publicado: (2015)

Interstitial Pneumonia With Autoimmune Features (IPAF)
por: Fernandes, Ligia, et al.
Publicado: (2019)

POLYMYOSITIS
Publicado: (1958)

Polymyositis
Publicado: (1899)

Is It Polymyositis?
por: Bansal, Tapesh
Publicado: (2023)

Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
por: Cheng, Shih-Lung, et al.
Publicado: (2021)

Tozinameran: Exacerbation of interstitial pneumonia: 2 case reports
Publicado: (2022)

Spontaneous Improvement of Interstitial Pneumonia with Autoimmune Features
por: Oda, Keishi, et al.
Publicado: (2017)

Interstitial pneumonia with autoimmune features: challenges and controversies
por: Mackintosh, John A., et al.
Publicado: (2021)

A case of thymoma-associated multiorgan autoimmunity including polymyositis and myocarditis
por: Furuta, Chihiro, et al.
Publicado: (2021)

Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia
por: Ushiki, Atsuhito, et al.
Publicado: (2014)

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases
por: Suda, Takafumi, et al.
Publicado: (2009)

Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
por: Higo, Hisao, et al.
Publicado: (2022)

A predictive model for acute exacerbation of idiopathic interstitial pneumonias
por: Karayama, Masato, et al.
Publicado: (2023)

Nailfold capillaroscopy findings of interstitial pneumonia with autoimmune features
por: Lee, Sang-Heon, et al.
Publicado: (2023)

A Case of Atorvastatin-Associated Necrotizing Autoimmune Myopathy, Mimicking Idiopathic Polymyositis
por: Dixit, Ayushi, et al.
Publicado: (2018)

The clinical application of tumor markers in the screening of malignancies and interstitial lung disease of dermatomyositis/polymyositis patients: A retrospective study
por: Lim, Chong Hong, et al.
Publicado: (2018)

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease
por: Enomoto, Yasunori, et al.
Publicado: (2017)

LABA/LAMA fixed-dose combinations versus LAMA monotherapy in the prevention of COPD exacerbations: a systematic review and meta-analysis
por: Chen, Ching-Yi, et al.
Publicado: (2020)

Survey of acute exacerbation after nonpulmonary surgery in patients with interstitial pneumonia
por: Hamada, Miho, et al.
Publicado: (2021)

Evaluation and Management of Polymyositis
por: Hunter, Kathy, et al.
Publicado: (2012)

Nutrition and Polymyositis and Dermatomyositis
por: Loell, Ingela, et al.
Publicado: (2008)

Interstitial pneumonia with autoimmune features: an additional risk factor for ARDS?
por: Grasselli, Giacomo, et al.
Publicado: (2017)

Interstitial pneumonia with autoimmune features: A case series and overview
por: Fernandes, Ana Luísa, et al.
Publicado: (2021)

Rituximab for interstitial pneumonia with autoimmune features at two medical centres
por: D’Silva, Kristin M, et al.
Publicado: (2021)

Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know
por: Joerns, Elena K., et al.
Publicado: (2022)

Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis
por: Zhang, Li, et al.
Publicado: (2016)

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease
por: Shu, Xiaoming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aqq5oa2rl7dkaoe0rleu9ihu2p